2027 Co-op Viral Vector Process Development

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. Regeneron is currently seeking multiple 2027 Co-ops in Viral Vector Process Development to join our Viral Production Core within Preclinical Manufacturing and Process Development (PMPD), which develops the processes used to produce and purify adeno-associated virus (AAV) for gene therapy programs. These positions offer the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.

When & Where

Location: Tarrytown, NY

Timeframe: Our Co-op positions are full-time and onsite from January-August (Spring-Summer), May/June-December (Summer-Fall), and August-December (Fall).

Pay: Intern and Co-op pay ranges are determined by level of education (year in school) and degree program. The hourly rate range for these locations is: $17.90-$50.90 per hour.

What You’ll Do

• Support the development of upstream and downstream processes used to produce and purify adeno-associated virus (AAV) for gene therapy programs
• Optimize cell culture conditions to improve viral production
• Develop high-throughput purification workflows for viral vectors
• Build models to predict and improve separation performance
• Conduct wet-lab experiments and analyze the resulting data
• Collaborate with scientists across upstream and downstream teams
• Document experimental procedures and results
• Present progress and findings to the broader team

Relevant Majors

Chemical/Biochemical Engineering, Biochemistry, Microbiology, Molecular Biology

Fit Criteria

• Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
• Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
• Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
• Cumulative GPA of 3.0 or higher preferred

Benefits

Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role:

• annual bonuses or other incentive plans
• equity awards
• pension or retirement benefits
• 401(k) company match
• health and wellness programs
• fitness centers
• insurance benefits (e.g. medical, dental, vision, life and disability)
• paid time off
• family support benefits

For additional information about Regeneron benefits in the U.S., please visit

Equal Opportunity

We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.

Other Information

As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications.

For jobs in Canada: this posting is for an existing position.

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.